CLINICAL UPDATES ON NEUROTHERAPEUTICS: DISEASE STATE

This plenary session will provide clinicians and clinical investigators with an up-to-date overview of state of the art treatment in three key disease states: bipolar disorder, posttraumatic stress disorder, and schizophrenia. An expert panel will discuss current literature and findings from clinical trials as translating to everyday real-world clinical practice. Presentations will include an in-depth focus on the merits and shortcomings of guideline-based treatment for bipolar disorder and devising optimal treatment protocols and paradigms; the emerging role of second generation antipsychotics (SGAs) as foundational treatments for bipolar disorder and short-and long-term breadth of spectrum relative to that of mood stabilizers such as lithium, valproate or lamotrigine; new findings in the pharmacotherapy of posttraumatic stress disorder; and contemporary approaches (and newly emerging treatment options) for the management of schizophrenia.